Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    February 2017
  1. CHASSOUX F, Artiges E, Semah F, Laurent A, et al
    18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003714.
    PubMed     Text format     Abstract available


  2. LOCKHART SN, Ayakta N, Winer JR, La Joie R, et al
    Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003724.
    PubMed     Text format    


  3. KREISL WC, Lawrence R, Page E, Teich AF, et al
    11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
    PubMed     Text format    


    January 2017
  4. SPINA S, Schonhaut DR, Boeve BF, Seeley WW, et al
    Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003636.
    PubMed     Text format     Abstract available


  5. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


    October 2016
  6. KIKUCHI A, Okamura N, Hasegawa T, Harada R, et al
    In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Neurology. 2016 Oct 28. pii: 10.1212/WNL.0000000000003375.
    PubMed     Text format     Abstract available


    September 2016
  7. GUROL ME, Becker JA, Fotiadis P, Riley G, et al
    Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.
    Neurology. 2016 Sep 7. pii: 10.1212/WNL.0000000000003197.
    PubMed     Text format     Abstract available


    August 2016
  8. WALKER Z, Moreno E, Thomas A, Inglis F, et al
    Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.
    Neurology. 2016 Aug 10. pii: 10.1212/WNL.0000000000003076.
    PubMed     Text format     Abstract available


    July 2016
  9. CAVALLARO T, Klunk W
    PiB-PET detects transthyretin-related cerebral amyloid angiopathy.
    Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003018.
    PubMed     Text format    


  10. GOTTESMAN RF, Schneider AL, Zhou Y, Chen X, et al
    The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002914.
    PubMed     Text format     Abstract available


    June 2016
  11. CHO H, Choi JY, Hwang MS, Lee JH, et al
    Tau PET in Alzheimer disease and mild cognitive impairment.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002892.
    PubMed     Text format     Abstract available


    May 2016

  12. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2016;86:2116.
    PubMed     Text format    


  13. WERNER P, Saur D, Mildner T, Moller H, et al
    Combined PET/MRI: Multimodality insights into acute stroke hemodynamics.
    Neurology. 2016;86:1926-7.
    PubMed     Text format    


    March 2016
  14. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
    PubMed     Text format     Abstract available


  15. SCOTT G, Ramlackhansingh AF, Edison P, Hellyer P, et al
    Amyloid pathology and axonal injury after brain trauma.
    Neurology. 2016;86:821-8.
    PubMed     Text format     Abstract available


    February 2016
  16. ROUSSAKIS AA, Politis M, Towey D, Piccini P, et al
    Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.
    Neurology. 2016 Feb 26. pii: 10.1212/WNL.0000000000002494.
    PubMed     Text format     Abstract available


  17. VERA JH, Guo Q, Cole JH, Boasso A, et al
    Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.
    Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002485.
    PubMed     Text format     Abstract available


  18. MARNANE M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, et al
    Periventricular hyperintensities are associated with elevated cerebral amyloid.
    Neurology. 2016;86:535-43.
    PubMed     Text format     Abstract available


    January 2016
  19. NERRANT E, Fourcade C, Coulette S, Lechiche C, et al
    Teaching NeuroImages: Extensive vasogenic edema in Bickerstaff brainstem encephalitis.
    Neurology. 2016;86:e38-9.
    PubMed     Text format    


  20. RUSSELL DS, Jennings DL, Barret O, Tamagnan GD, et al
    Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Neurology. 2016 Jan 22. pii: 10.1212/WNL.0000000000002391.
    PubMed     Text format     Abstract available


  21. STOESSL AJ
    Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
    Neurology. 2016;86:228.
    PubMed     Text format    


  22. DEL CAMPO N, Payoux P, Djilali A, Delrieu J, et al
    Relationship of regional brain beta-amyloid to gait speed.
    Neurology. 2016;86:36-43.
    PubMed     Text format     Abstract available


    December 2015
  23. PAYER DE, Guttman M, Kish SJ, Tong J, et al
    D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002285.
    PubMed     Text format     Abstract available


  24. LOHLE M, Mende J, Wolz M, Beuthien-Baumann B, et al
    Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002286.
    PubMed     Text format     Abstract available


    November 2015
  25. CANOSA A, Pagani M, Cistaro A, Montuschi A, et al
    18F-FDG-PET correlates of cognitive impairment in ALS.
    Neurology. 2015 Nov 20. pii: 10.1212/WNL.0000000000002242.
    PubMed     Text format     Abstract available


  26. CHRISTENSEN S, Obi C, Albers G, Lansberg M, et al
    Ultra-acute CT perfusion imaging: A stroke in the scanner.
    Neurology. 2015;85:1725-6.
    PubMed     Text format    


    October 2015
  27. ZWAN MD, Rinne JO, Hasselbalch SG, Nordberg A, et al
    Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2015 Oct 14. pii: 10.1212/WNL.0000000000002081.
    PubMed     Text format     Abstract available


    September 2015
  28. PALMQVIST S, Zetterberg H, Mattsson N, Johansson P, et al
    Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001991.
    PubMed     Text format     Abstract available


  29. LEE DH, Oh JS, Ham JH, Lee JJ, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001999.
    PubMed     Text format     Abstract available


    August 2015
  30. ALPERT JN, Saidha S, Al-Louzi O
    Biopsy-negative PET-positive giant-cell arteritis.
    Neurology. 2015;85:743.
    PubMed     Text format    


  31. NIRENBERG MJ
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2015;85:483.
    PubMed     Text format    


    July 2015
  32. LIU E, Schmidt ME, Margolin R, Sperling R, et al
    Amyloid-beta 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001877.
    PubMed     Text format     Abstract available


  33. BREITNER JC
    Yet another "disconnect" between amyloid and Alzheimer disease?
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001871.
    PubMed     Text format    


  34. TOLEDO JB, Bjerke M, Chen K, Rozycki M, et al
    Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.
    Neurology. 2015;85:144-53.
    PubMed     Text format     Abstract available


  35. KIM HJ, Im K, Kwon H, Lee JM, et al
    Clinical effect of white matter network disruption related to amyloid and small vessel disease.
    Neurology. 2015;85:63-70.
    PubMed     Text format     Abstract available


  36. AMARIGLIO RE, Mormino EC, Pietras AC, Marshall GA, et al
    Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly.
    Neurology. 2015;85:56-62.
    PubMed     Text format     Abstract available


    June 2015
  37. COSGROVE J, Jamieson S, Chowdhury FU
    Teaching NeuroImages: Hypometabolism of the primary motor cortex in primary lateral sclerosis: The stripe sign.
    Neurology. 2015;84:e206.
    PubMed     Text format    


  38. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Author Response.
    Neurology. 2015;84:2292.
    PubMed     Text format    


  39. MULLER ML, Albin RL, Bohnen NI, Jennings D, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2015;84:2292.
    PubMed     Text format    


    May 2015
  40. BRIDEL C, Garibotto V
    Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.
    Neurology. 2015;84:e159.
    PubMed     Text format    


  41. LEVENTER RJ, Scerri T, Marsh AP, Pope K, et al
    Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Neurology. 2015;84:2029-32.
    PubMed     Text format     Abstract available


  42. CAMPBELL MC, Koller JM, Snyder AZ, Buddhala C, et al
    CSF proteins and resting-state functional connectivity in Parkinson disease.
    Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001681.
    PubMed     Text format     Abstract available


  43. GROWDON ME, Schultz AP, Dagley AS, Amariglio RE, et al
    Odor identification and Alzheimer disease biomarkers in clinically normal elderly.
    Neurology. 2015 May 1. pii: 10.1212/WNL.0000000000001614.
    PubMed     Text format     Abstract available


    January 2015
  44. WING YK, Lam SP, Zhang J, Leung E, et al
    Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression.
    Neurology. 2015 Jan 7. pii: 10.1212/WNL.0000000000001215.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: